Sleep Apnea Devices Market: Introduction
According to the report, the global sleep apnea devices market was valued at US$ 7 Bn in 2020 and is projected to expand at a CAGR of 8.5% from 2021 to 2028. Sleep apnea is a serious sleep disorder, in which a person’s breathing is interrupted while sleeping. Untreated sleep apnea causes people to stop breathing frequently during the night, sometimes hundreds of times.
The three types of sleep apnea are obstructive, central, and mixed. Obstructive sleep apnea (OSA) is the most common of the three. Obstructive sleep apnea occurs when the upper airway is partially or completely blocked during sleep. During an apnea episode, the diaphragm and chest muscles work harder to open the airway as the pressure rises.
Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=588
Increase in Number of Undiagnosed Sleep Apnea Patients Globally
Sleep disorders, including sleep apnea, have emerged as a major public health concern in the U.S. Sleep apnea affects an estimated 22 million people in the U.S., with 80% of moderate and severe obstructive sleep apnea cases going undiagnosed. OSA, which accounts for the majority of cases, could lead to high blood pressure, chronic heart failure, atrial fibrillation, stroke, and other cardiovascular problems if left untreated. It is linked to type 2 diabetes and depression, and is a factor in a number of traffic accidents and accidents involving heavy machinery due to the persistent drowsiness experienced by many OSA patients before the disease is recognized and treated.
Polysomnography (PSG) Devices Segment to Dominate Market
In terms of diagnostic device, the global sleep apnea devices market has been classified into actigraphy systems, polysomnography (PSG) devices, respiratory polygraph, and single-channel screening devices (pulse oximeters). The polysomnography (PSG) devices segment accounted for a major share of the global market in 2020. Polysomnography (PSG), a type of sleep study, is a multiparametric test used in sleep research and as a diagnostic tool in sleep medicine.
Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=588
Preference for Positive Airway Pressure (PAP) Devices
Based on therapeutic device, the global sleep apnea devices market has been classified into airway clearance systems, adaptive servo-ventilation (ASV), positive airway pressure (PAP) devices, oral appliances, oxygen devices, and others. Positive airway pressure (PAP) devices are the most commonly used therapeutic devices to treat sleep apnea.
Among PAP devices, continuous positive airway pressure (CPAP) devices are the preferred choice of therapy for OSA among healthcare providers globally. The high efficacy of CPAP and other PAP devices in treating sleep apnea has increased the adoption of therapeutic devices.
North America to Lead Global Market
In terms of region, the global sleep apnea devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global sleep apnea devices market in 2020 due to higher prevalence of sleep apnea and favorable reimbursement policies, which have been critical in the region’s higher adoption of sleep apnea devices.
The market in Europe is expected to be driven by rise in awareness about sleep apnea, increase in need of diagnostic tests, and high adoption of sleep apnea devices. The sleep apnea devices market in Asia Pacific is likely to grow at rapid pace during the forecast period due to increase in demand for devices in countries such as Japan and Australia and rise in prevalence of sleep apnea in developing countries.
Make an Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=588
The global sleep apnea devices market is fragmented, in terms of number of players. Key players in the global market include ResMed, Inc., BMC Medical Co., Ltd., Braebon Medical Corporation, Compumedics Limited, Devilbiss Healthcare LLC, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Löwenstein Group, Oventus Medical, Panthera Dental, SomnoMed Limited, and Whole You (subsidiary of Mitsui Chemicals, Inc.).
Related Report –
Biosimilar and Follow-On Biologics Market: https://www.biospace.com/article/biosimilar-and-follow-on-biologics-market-demand-and-growth-analysis-with-forecast-up-to-2031/
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Nikhil Sawlani Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-345